AR and glioblastoma: AR is overexpressed in 56% of glioblastoma multiforme (GBM) specimens and AR antagonists induced dose-dependent death in several GBM cell lines and significantly reduced tumor growth and prolonged the lifespan of mice implanted with human GBM.